Transcriptomics and RNA-Seq

Core Concept

Transcriptomics is the genome-wide study of the transcriptome — the complete set of RNA transcripts a cell or tissue produces under given conditions. Its flagship method, RNA-Seq, converts RNA to a cDNA library, sequences millions of fragments with high-throughput sequencing, then computationally aligns reads to a reference genome/transcriptome and counts how many reads map to each gene. Read counts serve as a digital measure of expression, enabling genome-wide discovery of which genes are on, how much, and in which splice isoforms — without the need to know targets in advance. RNA-Seq measures RNA abundance, not protein, and reveals correlates of gene activity that still require functional validation.

Key Components

RNA extraction and enrichment

• Total RNA (or poly(A)-selected mRNA, or rRNA-depleted RNA) is isolated; RNA quality (RIN) is checked because degraded input biases results.

cDNA library preparation

• RNA is reverse-transcribed to cDNA, fragmented, and ligated to sequencing adapters; each fragment may be tagged with a molecular barcode for accurate counting.

High-throughput sequencing

• The library is sequenced (typically Illumina short reads) to produce millions of reads representing the original transcripts.

Alignment and quantification

• Reads are mapped to a reference genome or transcriptome; the number of reads per gene/transcript is counted and normalized (RPKM/FPKM/TPM) to account for gene length and library size.

Differential expression and isoform analysis

• Statistical tests compare counts across conditions to find differentially expressed genes; splicing-aware tools reconstruct transcript isoforms.

Mechanism

1. Extract and QC RNA. Isolate RNA and verify integrity.
2. Build library. Convert RNA to cDNA, fragment, add adapters (and barcodes).
3. Sequence. Generate millions of short reads.
4. Align. Map reads to the reference genome/transcriptome (or assemble de novo).
5. Quantify. Count reads per gene and normalize (TPM/FPKM) to estimate expression.
6. Analyze. Perform differential expression testing, detect isoforms/novel transcripts, then validate key hits by RT-qPCR.

Energy and Directionality

RNA-Seq is not an enzymatic assay in the cell — its "directionality" is informational. Reads are sequenced 5′→3′ (polymerase-driven, powered by dNTP hydrolysis during sequencing-by-synthesis), and the alignment step assigns each read to a genomic coordinate, converting sequence into a quantitative expression vector. The biological signal (mRNA abundance) is inferred from read counts, so the method reports steady-state transcript levels — the net of transcription and degradation — not rates.

Experimental Evidence

• What it measures: genome-wide RNA abundance (expression), plus splicing/isoform structure and, with scRNA-Seq, cell-to-cell heterogeneity.
• Principle: high-throughput sequencing of cDNA from cellular RNA + alignment + counting.
• Input: RNA (cells/tissue); Output: a count/abundance matrix (genes × samples), lists of differentially expressed genes, and detected isoforms/novel transcripts.
• What it can prove: which genes are transcribed and to what relative level across conditions; splicing differences; discovery of novel transcripts and non-coding RNAs (no prior probe design needed); (via single-cell RNA-Seq) expression at the level of individual cells.
• What it cannot prove: protein abundance or activity (mRNA-protein discordance is common); post-translational regulation; causal mechanisms (expression changes are correlations); absolute copy number without spike-in standards.
• Controls/quality steps: biological and technical replicates; RNA integrity (RIN) and library-quality checks; spike-in controls (known synthetic RNAs) for absolute calibration; batch correction; and validation of key genes by RT-qPCR (the orthogonal gold standard).
• Common mistakes: ignoring RNA quality (degradation skews counts); insufficient replicates (statistical power); library-size/gene-length normalization errors; conflating mRNA change with protein change; and over-interpreting a correlation as mechanism.

Common confusions

• "RNA-Seq = DNA sequencing of the genome" — RNA-Seq sequences cDNA from RNA, measuring expression; whole-genome sequencing reads DNA.
• "RNA-Seq replaces RT-qPCR" — RNA-Seq is discovery/global; RT-qPCR remains the targeted validation standard.
• "High mRNA = high protein" — Translation and protein turnover decouple them; confirm protein separately.
• "TPM and raw counts are the same" — TPM/FPKM are normalized for gene length and library size; raw counts are not comparable across genes/samples without normalization.
• "A differentially expressed gene is causally important" — It is a candidate; mechanism needs functional experiments.

Quick review

• RNA → cDNA library → high-throughput sequencing → align to reference → count reads → normalize (TPM) → differential expression.
• Measures transcriptome-wide RNA abundance and isoforms; discovery without probes.
• RNA ≠ protein; expression changes are correlations needing functional validation.